申请人:GRACZYK Piotr Pawel
公开号:US20100069358A1
公开(公告)日:2010-03-18
The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them.
本发明提供了一种化合物(I)或其药学上可接受的盐,用于抑制c-Jun N末端激酶(JNK)活性,特别是用于治疗神经退行性疾病、炎症性疾病和/或自身免疫性疾病。本发明还提供了制备该化合物(I)或其药学上可接受的盐的方法和含有它们的组合物。